Delivery Order SPE2DB20D3104-SPE2DB25FV8U7
- Not listed
- The Defense Logistics Agency awarded a $31,296 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe form, with an ultimate completion date of August 25, 2025. The contract, which is non-set-aside and competitively awarded, will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under AmerisourceBergen's broader contract vehicle with DLA. This award is issued as a child...
- The Defense Logistics Agency awarded a $1,761.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe form, with a completion deadline of November 4, 2025. The contract, issued on November 3, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,502.89 delivery order on July 21, 2025, for Twinrix vaccine in syringe form, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,707.70 to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe format. This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,215.76 to AmerisourceBergen Drug Corp for TWINRIX vaccine syringes, with an ultimate completion date of October 31, 2025. This is a firm fixed price, non-set-aside contract for delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a delivery order valued at $91,647.30 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This competitively awarded, firm fixed-price contract was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Twinrix vaccine in syringe format, with a ceiling value of $17,246.08 and a firm fixed price structure. This non-competitive delivery order is set to conclude on May 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TWINRIX vaccine in syringe form, valued at $1,282.36, with an award date of June 12, 2025 and ultimate completion date of June 13, 2025. The contract employs firm fixed price pricing and was competitively awarded with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,822.80 for TWINRIX vaccine syringes (1mL, 10-count units) under a firm fixed-price contract. The award, issued on August 1, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive, non-set-aside procurement. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $12,530.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe format, with an ultimate completion date of November 17, 2025. This non-set-aside delivery order was competitively awarded and represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with the federal government. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV8U7Delivery Order
The Defense Logistics Agency awarded a $37,997.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe format, with a completion date of July 14, 2025. The contract, awarded on July 11, 2025, represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates proven capability to meet Defense Department procurement requirements through open competition, delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This TWINRIX vaccine award reflects the contractor's continued role in supporting the Defense Health Agency and other government healthcare systems with essential pharmaceutical commodities through DLA's flexible contracting vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.0k | 7/11/25 |